Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. A critical conside...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESMO Open
Auteurs principaux: Tabernero, Josep, Vyas, Malvika, Giuliani, Rosa, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo G, Cervantes, Andres, Eggermont, Alexander MM, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, Rauh, Stefan, Zielinski, Christoph C, Stahel, Rolf A, Voest, Emile, Douillard, Jean-Yves, McGregor, Keith, Ciardiello, Fortunato
Format: Artigo
Langue:Inglês
Publié: ESMO Open 2017
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5419210/
https://ncbi.nlm.nih.gov/pubmed/28848668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000142
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires